ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2026
Spacer-free but prolene mesh-supported girdlestone resection arthroplasty achieves reliable ınfection eradication and pain relief in high-risk patients: 5-year outcomes.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveGirdlestone resection arthroplasty (GRA) remains the final salvage procedure for eradicating chronic hip infections, particularly in cases where reimplantation is not feasible. However, data on GRA performed without an antibiotic spacer are limited. This study aimed to evaluate mid-term infection control, patient-centered functional outcomes, and associated risk factors in patients who underwent spacer-free but prolene mesh-supported GRA.
methodsTwenty patients (mean age: 62.2 ± 17.1; 9 males and 11 females) who underwent spacer-free GRA between 2011 and 2020 and were followed for at least 5 years were retrospectively reviewed. Demographic data, comorbidities (ASA, Charlson Comorbidity Index, corticosteroid use), surgical and microbiological characteristics, and functional scores (Merle d'Aubigné-Postel [MAP], Harris Hip Score [HHS], Oxford Hip Score [OHS], visual analog scale [VAS], and walking distance) were recorded. Subgroup analyses were performed according to LLD ≥ 5 cm, corticosteroid use, and ASA ≥ 3. Infection-free survival was assessed using Kaplan-Meier analysis.
resultsAt five-year follow-up, infection-free survival was observed in all patients (100%; 95% CI 83-100). The mean MAP score increased from 6.0 to 8.0 (mean difference = 2.0 [CI 0.5-3.5]; p = 0.22), HHS from 30.0 to 35.0 (p = 0.18), and OHS from 15.0 to 18.0 (p = 0.24). VAS at rest decreased significantly (4.5 → 3.0; p = 0.04), and walking distance increased from 120 to 355 m (p = 0.01). Patients with LLD ≥ 5 cm had significantly lower MAP scores (p = 0.04). These findings represent observational outcomes derived from a retrospective single-arm case series.
conclusionSpacer-free but prolene mesh-supported GRA may represent a viable salvage option for infection control and pain relief in high-risk patients, although functional recovery remains limited.
Indexed as
Identifiers
41670737What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.